Governments and WHO Changed COVID-19 Policy Based On Suspect Data From Tiny US Company

AmiMoJo shares a report from The Guardian The World Health Organization and a number of national governments have changed their Covid-19 policies and treatments on the basis of flawed data from a little-known U.S. healthcare analytics company, also calling into question the integrity of key studies published in some of the world's most prestigious medical journals. Surgisphere, whose employees appear to include a sci-fi writer and adult content model, provided the database behind Lancet and New England Journal of Medicine hydroxychloroquine studies. Data it claims to have legitimately obtained from more than a thousand hospitals worldwide formed the basis of scientific articles that have led to changes in Covid-19 treatment policies in Latin American counties. It was also behind a decision by the WHO and research institutes around the world to halt trials of the controversial drug hydroxychloroquine. Late on Tuesday, the Lancet released an "expression of concern" about its published study. The New England Journal of Medicine has also issued a similar notice. According to an independent audit by authors not affiliated with Surgisphere, the article includes a list of "concerns that have been raised about the reliability of the database." Some of the main points include: Surgisphere's employees have little or no data or scientific background; While Surgisphere claims to run one of the largest and fastest growing hospital databases in the world, it has almost no online presence; and The firm's chief executive, Sapan Desai, has been named in three medical malpractice suits.

Read more of this story at Slashdot.